Dr. Alan COLMAN Principal Investigator, Institute of Medical Biology and Executive Director, Singapore Stem Cell Consortium, Agency for Science, Technology and Research (A*STAR), Singapore; Professor of Regenerative Medicine and Director, Stem Cell Centre, King's College London
CV
| 1974-1976 | Demonstrator in Developmental Biology, Zoology Department, Oxford University |
| 1976-1983 | Lecturer in Department of Biological Sciences, University of Warwick, Coventry |
| 1983-1987 | Senior Lecturer, Department of Biological Sciences, University of Warwick, Coventry |
| 1987-1993 | Professor, Department of Biochemistry, University of Birmingham |
| 1988-1993 | Research Director, PPL Therapeutics plc, Edinburgh, UK (part-time) |
| 1993-2002 | Research Director, PPL Therapeutics plc, Edinburgh, UK (full-time) |
| 2002-2005 | Chief Scientific Officer, ES Cell International, Singapore |
| since 2002 | Adjunct Professor, Department of Biochemistry, National University of Singapore |
| since 2004 | Senior Scientist, Center for Molecular Medicine, Biomedical research Institute, Singapore |
| 2005-2007 | Chief Executive Officer, ES Cell International, Singapore |
| since 2007 | Executive Director of the A*STAR Stem Cell Consortium |
| since 2008 | Professor of Regenerative Medicine and Director of the Stem Cell Centre, King's College, London |
Mitgliedschaften
| American Society of Cell Biology | |
| International Society of Stem Cell research | |
| European Molecular Biology Organization |
Publikationen
| Selected: | |
| Human Factor IX transgenic sheep produced by transfer of nuclei from transfected fetal oocytes, Science 278, 1997 | |
| The Future of Cloning, Nature 402, 1999 | |
| Production of gene-targeted sheep by nuclear transfer from cultured somatic cells, Nature 405, 2000 | |
| Cloned pigs produced by nuclear transfer from adult somatic cells, Nature 407, 2000 | |
| Induced pluripotent stem cells and the stability of the differentiated state. EMBO Reports 10, 2009 |
